16.03.2018
- ABL Europe has successfully increased and brought online new viral vector manufacturing capacity at its European facility in Strasbourg. A subsidiary of ABL Inc., ABL Europe has...
15.03.2018
- Hamburg, Germany-based drug development specialist Evotec and French drugmaker Sanofi have entered into exclusive negotiations calling for Evotec to accelerate infectious disease...
02.03.2018
- Sanofi has received all the necessary regulatory approvals for its planned €3.9 billion takeover of Belgian biotech Ablynx. The deal was announced on Jan. 29. The next step is to...
27.02.2018
- Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the...
04.02.2018
- Lending fuel to the ongoing controversy in the Philippines over the possible side effects of Sanofi Pasteur 's Dengue vaccine Dengvaxia, an initial report by the Philippine General...
30.01.2018
- Sanofi is to acquire Belgium biopharma Ablynx in a deal valued at around €3.9 billion. The announcement comes just days after the French drugmaker announced its intention to buy US...
24.01.2018
- Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...
23.01.2018
- French vaccines producer Sanofi Pasteur, under pressure from the government of the Philippines, has agreed to refund the country $28 million for unused doses of its Dengvaxia...
08.01.2018
- The year just ended was marked by a flood of M&A activity also in the distribution sector. Leading the way, German giant Brenntag said it planned to acquire all shares of specialty...
08.01.2018
- On the pharmaceutical side, super-dimensioned M&A activity was somewhat more modest. Many of the deals were between players in the biochemicals segment or conventional drugmakers...
